Trial intelligence / Profile preview

Exercise and Blood Glucose Levels in Patients with Type I Diabetes - a Pilot Study

2013-004631-77Phase 4Completed

Sponsor
Medical University of Graz
Start
Jan 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of insulin degludec in diabetes mellitus type 1 (T1D), sponsored by Medical University of Graz. Primary endpoints: Absence of hypoglycemia during exercise and Absence of post-exercise hypoglycemia. Started Jan 2014; status: completed.

02

Drugs

insulin degludec
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2013-004631-77.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004631-77.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call